JP2022527865A5 - - Google Patents
Info
- Publication number
- JP2022527865A5 JP2022527865A5 JP2021560628A JP2021560628A JP2022527865A5 JP 2022527865 A5 JP2022527865 A5 JP 2022527865A5 JP 2021560628 A JP2021560628 A JP 2021560628A JP 2021560628 A JP2021560628 A JP 2021560628A JP 2022527865 A5 JP2022527865 A5 JP 2022527865A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- stress
- induced
- stressor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962831517P | 2019-04-09 | 2019-04-09 | |
| US62/831,517 | 2019-04-09 | ||
| US201962857075P | 2019-06-04 | 2019-06-04 | |
| US62/857,075 | 2019-06-04 | ||
| US201962910859P | 2019-10-04 | 2019-10-04 | |
| US62/910,859 | 2019-10-04 | ||
| PCT/US2020/027321 WO2020210393A1 (en) | 2019-04-09 | 2020-04-08 | Prophylactic efficacy of serotonin 4 receptor agonists against stress |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022527865A JP2022527865A (ja) | 2022-06-06 |
| JP2022527865A5 true JP2022527865A5 (https=) | 2023-04-13 |
| JP7683882B2 JP7683882B2 (ja) | 2025-05-27 |
Family
ID=72750568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021560628A Active JP7683882B2 (ja) | 2019-04-09 | 2020-04-08 | ストレスに対するセロトニン４受容体アゴニストの予防的有効性 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220031684A1 (https=) |
| EP (1) | EP3952852A4 (https=) |
| JP (1) | JP7683882B2 (https=) |
| CN (1) | CN113924087A (https=) |
| AU (1) | AU2020271839B2 (https=) |
| CA (1) | CA3136328A1 (https=) |
| MX (1) | MX2021012394A (https=) |
| WO (1) | WO2020210393A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7821116B2 (ja) * | 2020-04-07 | 2026-02-26 | ザ トラスティーズ オブ コロンビア ユニバーシティー イン ザ シティー オブ ニューヨーク | ストレス誘導性恐怖、うつ様行動および不安様行動の予防のための組成物および方法 |
| EP4577305A2 (en) * | 2022-08-25 | 2025-07-02 | 1/1The Trustees Of Columbia University In The City Of New York | Compositions and methods for the treatment of alzheimer's disease and other neurogenerative disease |
| CN118105081B (zh) * | 2024-03-04 | 2025-02-11 | 天津大学 | 一种情绪状态与神经电生理状态调节装置、验证系统及方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2846559B1 (fr) * | 2002-10-31 | 2007-06-15 | Centre Nat Rech Scient | Composition pharmaceutique pour la preparation d'un medicament destine a traiter et/ou a prevenir une pathologie liee a une conduite obsessionnelle |
| US20090170899A1 (en) | 2004-09-14 | 2009-07-02 | Guy Debonnel | Stimulators of 5-HT4 receptors and uses thereof |
| EP2640398A4 (en) | 2010-11-18 | 2014-05-14 | White Mountain Pharma Inc | METHOD FOR TREATING CHRONIC OR BZW. NON-RELIABLE PAIN AND / OR INCREASE OF PATIENT PAIN THRESHOLD AND PHARMACEUTICAL COMPOSITION FOR USE THEREOF |
| US11110070B2 (en) | 2015-11-17 | 2021-09-07 | The Trustees Of Columbia University In The City Of New York | Pharmacological prophylactics against stress-induced affective disorders and their associated symptoms |
-
2020
- 2020-04-08 CN CN202080042252.4A patent/CN113924087A/zh active Pending
- 2020-04-08 WO PCT/US2020/027321 patent/WO2020210393A1/en not_active Ceased
- 2020-04-08 EP EP20786878.7A patent/EP3952852A4/en active Pending
- 2020-04-08 MX MX2021012394A patent/MX2021012394A/es unknown
- 2020-04-08 JP JP2021560628A patent/JP7683882B2/ja active Active
- 2020-04-08 AU AU2020271839A patent/AU2020271839B2/en active Active
- 2020-04-08 CA CA3136328A patent/CA3136328A1/en active Pending
-
2021
- 2021-10-05 US US17/494,218 patent/US20220031684A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shelton | Serotonin and norepinephrine reuptake inhibitors | |
| JP2022527865A5 (https=) | ||
| JP2013544850A5 (https=) | ||
| JP2024522065A5 (https=) | ||
| JP2016506933A5 (https=) | ||
| JP7158425B2 (ja) | Ｎｋ－１アンタゴニスト組成物およびうつ病の処置における使用法 | |
| BRPI0707495A2 (pt) | método para tratar ou reduzir os sintomas de esquizofrenia, uso de um abridor seletivo de canal de potássio kcnq, método de triagem de um composto, e, uso de um composto | |
| US20210161880A1 (en) | Methods for treating dementia related psychosis | |
| KR100842694B1 (ko) | 기분 장애 치료용 카르보스티릴 유도체 및 세로토닌 재흡수억제제 | |
| TW200800148A (en) | Use of agomelatine in obtaining medicaments intended for the treatment of sleep disorders in the depressed patient | |
| Kennedy | Agomelatine: efficacy at each phase of antidepressant treatment | |
| CN101257907A (zh) | 左旋佐匹克隆和抗抑郁剂的组合 | |
| JP5634529B2 (ja) | 強迫性障害（ｏｃｄ）処置用の薬剤の製造のためのアゴメラチンの使用 | |
| JP5341037B2 (ja) | 双極性障害を処置するための医薬を得るためのアゴメラチンの使用 | |
| JP2011516604A (ja) | 鬱病患者の自殺行動の予防治療のためのミルナシプラン塩酸塩の（１ｓ，２ｒ）鏡像異性体の使用 | |
| CN114585364A (zh) | 谷氨酸2b受体拮抗剂和σ受体激动剂作为止咳药的用途 | |
| JP2023509484A5 (https=) | ||
| JP5395998B2 (ja) | アゴメラチンとノルアドレナリン再取り込み阻害剤との新たな組み合わせ、及びそれを含有している医薬組成物 | |
| MX2009001219A (es) | Composicion farmaceutica que contiene en combinacion saredutant y un inhibidor selectivo de recaptacion de serotonina o un inhibidor de recaptacion de serotonina/norepinefrina. | |
| Stein et al. | P. 2. c. 001 Efficacy of the novel antidepressant agomelatine for anxiety symptoms within depression | |
| Raatjes et al. | Trazodone: the forgotten antidepressant | |
| JP2018509436A (ja) | ８−シクロプロピル−３−［２−（３−フルオロフェニル）エチル］−７，８−ジヒドロ−３ｈ−［１，３］オキサジノ［６，５−ｇ］［１，２，３］ベンゾトリアジン−４，９−ジオンと抗うつ剤との新規な組み合わせ、及びそれを含有する医薬組成物 | |
| NZ775671B2 (en) | New uses of a 5-ht4 receptor agonist | |
| TW202416952A (zh) | 治療cns病症之方法 | |
| JP2021031393A (ja) | 首下がり症候群の治療薬 |